Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-13

Clinical Trial Update: Liraglutide in the Treatment of Type 1 Diabetes Mellitus [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating liraglutide for treatment of Type 1 Diabetes Mellitus has completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liraglutide (liraglutide)

Snippet

Sponsor: University at Buffalo | Conditions: Type 1 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2015-03-13